GLO

Invest in GLO today!

Don't invest unless you're prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Watch the GLO community launch film

It's time to join the revolution and GLO

Watch our launch film and be part of the biggest moment in British cannabis history.

How we will use the funds

What the raise means for you and how you can be part of it

Listen to CEO Alex Fray talk about how you may benefit from investing including potential returns on your investment.

Serving our patients

A deeper dive into the Cancard partnership and how we will serve our patient communities

Carly speaks to what this project could mean for patients and why she is so passionate about the concept of a community owned business.

Technology

A look under the hood at our technology with a focus on the GLOchain

Charlie Lyons, our Chief Creative Officer, introduces our proprietary technology and how it can be utilised to support the company values.

Cultivation

How we will cultivate the best craft cannabis at scale in Britain

Charlie Price our Chief Scientific Officer explains the GLO cultivation philosophy. Our facility will combine the worlds best genetics with modular, highly controlled, growing environments that can optimised for each of our specific strains.

The Facility

How we will build a state of the art facility on the Isle of Man

Charlie Price takes you into the design of our main facility - The GrowLab.

Products

How we will make our products

Charlie explains the GLO approach to product development. Our facility will commercially produce 12-20 unique strains, available either as dried flower, as a solventless concentrate of the same batch of flower, or further processed into batch specific; vapes, oils and edibles. ​ Each of our products will have the unique range of cannabinoid and terpenes will be targeting specific medical conditions informed by our patient groups.

Research & Development

How you will be able to contribute to open-sourcing learning from cannabis

Charlie Lyons discusses the importance of contributing towards evidence that will support the use of medicinal cannabis for generations to come.

This has been approved as a financial promotion by Seedrs Limited on 1st June 2023 and is sent by GLO global Ltd.

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future. Seedrs or the fundraising business do not make investment recommendations to you and any investment decision should be made on the basis of the full campaign. No communications about any campaigns on Seedrs you receive from Seedrs or the fundraising business, through email or any other medium, should be construed as an investment recommendation.

GLO Coverage

As featured in

We are proud to have been featured by some of the leading media networks as we continue on our mission to help people live better lives through the power of cannabis.